CJEU GMO ruling could lessen CRISPR agri-patent worth but won’t stop filing
Modified crops can continue to be patented in Europe after the CJEU’s ruling that they should be regulated by the GMO directive, but stringent regulation could make those patents less valuable than agri-firms once hoped
In a ruling that could discourage investment in gene-editing
technologies such as CRISPR-Cas9, the CJEU has said that
modified crops should be subject to the same stringent
regulations as genetically modified organisms.
The judgment in the Confédération paysanne
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.